A Pharmacoeconomics Study for Anticoagulants used for Hospitalized COVID-19 Patients in Al-Najaf Al-Ashraf city -Iraq(Conference Paper )#

• Päätekijät: Fatimah Baqer Alqubbanchi (Tekijä), Fadya Yaqoob Al-Hamadani (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: College of Pharmacy University of Baghdad, 2022-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background: The novel coronavirus 2 (SARS?CoV?2) pandemic is a pulmonary disease, which leads to cardiac, hematologic, and renal complications. Anticoagulants are used for COVID-19 infected patients because the infection increases the risk of thrombosis. The world health organization (WHO),...